Position in NVS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,178,220
+$119,816 QoQ
Shares Held
7,518
+8.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#575
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 41%
Shared 59%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CENTRAL TRUST Co holds $179,391,267 across 15 Drug Manufacturers - General names. NVS ranks #10 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
215,195 | $54,151,669 | |
| 2 | LLY |
ELI LILLY & Co
|
42,110 | $50,508,000 | |
| 3 | JNJ |
Johnson & Johnson
|
114,703 | $29,131,120 | |
| 4 | MRK |
Merck & Co., Inc.
|
109,411 | $14,059,313 | |
| 5 | AMGN |
Amgen Inc
|
32,762 | $11,863,774 | |
| 6 | PFE |
Pfizer Inc
|
300,724 | $7,241,433 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
102,940 | $5,931,401 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
20,761 | $2,622,944 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,178,220 | 7,518 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,058,404 | 6,929 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $963,710 | 6,990 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $929,739 | 7,250 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $886,882 | 7,329 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $817,036 | 7,329 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $688,273 | 7,073 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $812,960 | 7,068 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $786,313 | 7,386 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $738,532 | 7,635 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $822,400 | 8,145 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $822,519 | 8,075 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $815,554 | 8,082 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $710,884 | 7,727 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $676,499 | 7,457 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $561,029 | 7,381 | Shares | Sole | 2022-11-17 | |
| 2022-06-30 | $678,353 | 8,025 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $748,068 | 8,525 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $733,785 | 8,389 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $693,739 | 8,483 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $792,236 | 8,683 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $725,126 | 8,483 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $978,011 | 10,357 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $940,732 | 10,818 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $1,111,139 | 12,722 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $1,088,999 | 13,208 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||